|Articles|February 1, 2004

Infection Control Today - 02/2004: References

A CLEAR VIEW: VISUALIZING THE IV FLUID PATH AS AN EMERGINGCONCEPT IN INFECTION CONTROL, BY MARILYN HANCHETT, RN, PHD, PAGE 36.

1. Hankins J, et al, editors, Infusion Therapy in ClinicalPractice. Philadelphia:W. B. Saunders Company, 2001, page 1.

2. Frequently Asked Questions, National Home InfusionAssociation web site (www.nhianet.org), 2003.

3. The Centers for Disease Control. Guidelines for thePrevention of Intravascular Catheter-Related Infections, MMWR Recommendationsand Reports, August 9, 2002/ 51(RR10) page. 3.

4. Crnich DJ, Maki DG. The promise of novel technology for the prevention of intravascular devicerelated bloodstream infection. II. Long-term devices. Clin Infect Dis. 2002 May 15; 34 (10):1362-8

5. Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults (abstract). In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology, 1999; 27: 520-532.


Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.